{"id":"W4322766543","doi":"10.1016/j.ejps.2023.106418","title":"Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19","year":2023,"lang":"en","type":"article","venue":"European Journal of Pharmaceutical Sciences","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity","funders":"Innovative Medicines Initiative; European Commission; Innovative Health Initiative; European Federation of Pharmaceutical Industries and Associations","keywords":"Pharmacokinetics; Repurposing; Pharmacodynamics; Coronavirus disease 2019 (COVID-19); Drug repositioning; Pharmacology; Imatinib; Medicine; 2019-20 coronavirus outbreak; Drug; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Internal medicine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002072763,0.0001637028,0.0003525033,0.0002256641,0.00015186,0.00004047636,0.0002866704,0.00001468805,0.0002289303],"category_scores_gemma":[0.0005112161,0.0001236715,0.0001182082,0.0005714174,0.0003563745,0.0001270184,0.0001376231,0.0002121656,0.0000103429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002272141,"about_ca_system_score_gemma":0.000503506,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002324048,"about_ca_topic_score_gemma":0.000001258281,"domain_scores_codex":[0.9979892,0.0002015902,0.0006333485,0.0002758451,0.0005463024,0.0003536909],"domain_scores_gemma":[0.9980521,0.0005717544,0.0003017269,0.00009179503,0.0001504818,0.000832167],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003620775,0.000519304,0.0199104,0.0008012604,0.0009015407,0.001521941,0.007216843,0.02536104,0.6135514,0.0001583329,0.03864556,0.2877916],"study_design_scores_gemma":[0.0391953,0.003002029,0.01241517,0.001410043,0.002940957,0.000773604,0.0020783,0.3294998,0.200404,0.0002277657,0.4071381,0.0009149369],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9870056,0.00162189,0.002138243,0.007686952,0.0005219293,0.0004217606,0.0001101345,0.00003389074,0.0004596084],"genre_scores_gemma":[0.9757585,0.002071881,0.01899392,0.00245032,0.0005186662,0.000005211721,0.000005694609,0.00003020611,0.0001655772],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4131474,"threshold_uncertainty_score":0.5043179,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1048869937484054,"score_gpt":0.4440031862422961,"score_spread":0.3391161924938906,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}